Drug Discovery App CS WP
-
CDMO Supports Complex Bispecific Antibody Development
4/13/2022
Read how the expertise, resources and flexibility of one partner have been fundamental in advancing novel and complex bispecific antibody candidates that target the WNT pathway.
-
mAbs Biotech Recognizes Value In Expertise, Track Record
4/13/2022
See how reputation for quality and experience with antibodies were driving forces in the CDMO selection for a CPI-006 antibody program.
-
Illustrating A Successful Small Biotech-CDMO Relationship
4/13/2022
Explore the experience of selecting and working with a global CDMO partner and the value for one virtual company established to develop the molecular design and process development for a complex protein.
-
Advanced Bioscience Laboratories Inc. (ABL) Scaled Up Lentiviral Production
3/30/2022
ABL scaled up the production of lentivirus from adherent cells in the iCELLis® bioreactor system, a well-established and proven technology accepted by regulatory agencies thus reducing risk and time to market.
-
Increased Productivity At The mAb Capture Step
3/24/2022
Biopharma company enjoys reductions in overall cost and upfront investment in their consumables with no change to the quality of the resulting product with a multicolumn format.
-
New Filtration Protocols Accelerate Viral Vector Development And Enhance Scale Up To Production
3/15/2022
Read how filtration technology is optimizing a scalable and GMP-compatible purification process for lentiviral vectors that works effectively from research and development through manufacturing.
-
Improve Single-Use Training Through Vendor And End-User Collaboration
3/14/2022
Learn more about a combination of teaching methodologies that facilitates engaging and efficient training of single-use technology (SUT) users of all skill levels.
-
Simplifying Tech Transfer With Automated Data Flow
3/11/2022
A pharmaceuticals development team struggling with disconnected and unstructured data sources improved their tech transfer process by simplifying data capture and aggregation.
-
Quantification Of Large Oligonucleotides Using High Resolution MS/MS
3/4/2022
Explore how to achieve sensitive, high-resolution analysis of large oligonucleotides, with the opportunity to perform both qualitative and quantitative analysis in a single run.
-
Extending The Lower Limits Of Quantification Of A Therapeutic Oligonucleotide Through Microflow LC-MS/MS
3/4/2022
Here a solution is presented to widely recognized challenges with ionpairing reversed phase liquid chromatography (IP-RP LC) through a novel microflow LC-MS strategy.